Publisher
Springer Science and Business Media LLC
Reference99 articles.
1. Tau N, Shargian-Alon L, Reich S, Paul M, Gafter-Gvili A, Shepshelovich D, et al. Reporting infections in clinical trials of patients with haematological malignancies. Clin Microbiol Infect. 2019;25(12):1494–500.
2. Cordonnier C, Maschmeyer G, Cesaro S, Ljungman P. Reporting infectious complications in haematology clinical trials should be improved. Clin Microbiol Infect. 2019;25(12):1451–3.
3. •• Fernandez-Ruiz M, Meije Y, Manuel O, Akan H, Carratala J, Aguado JM, et al. ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the Safety of targeted and biological therapies: an infectious diseases perspective (Introduction). Clin Microbiol Infect. 2018. This is a comprehesive collection of review articles on the infectious complications of biologicals and small mocules targeted therapies used in cancer, transplantation, autoimmune disorder, and rheumatological diseases.
4. • National comprehensive Cancer Network. Prevention and treatment of cancer-related infections version 2.2020 [Available from: https://www.nccn.org/professionals/physician_gls/pdf/infections.pdf. This is a continously updated online guidelines document on prevention and treatment of cancer-related infections.
5. •• Maschmeyer G, De Greef J, Mellinghoff SC, Nosari A, Thiebaut-Bertrand A, Bergeron A, et al. Infections associated with immunotherapeutic and molecular targeted agents in hematology and oncology. A position paper by the European Conference on Infections in Leukemia (ECIL). Leukemia. 2019;33(4):844–62 This is a review article on the infectious complications associated with agents used in hematology and oncology.